BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 2477702)

  • 1. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia.
    Goedert JJ; Kessler CM; Aledort LM; Biggar RJ; Andes WA; White GC; Drummond JE; Vaidya K; Mann DL; Eyster ME
    N Engl J Med; 1989 Oct; 321(17):1141-8. PubMed ID: 2477702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression to acquired immunodeficiency syndrome in 94 human immunodeficiency virus-positive hemophiliacs with long-term follow-up.
    Lorenzo JI; Moscardó F; López-Aldeguer J; Aznar JA
    Haematologica; 2001 Mar; 86(3):291-6. PubMed ID: 11357820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
    Volberding PA; Lagakos SW; Koch MA; Pettinelli C; Myers MW; Booth DK; Balfour HH; Reichman RC; Bartlett JA; Hirsch MS
    N Engl J Med; 1990 Apr; 322(14):941-9. PubMed ID: 1969115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term evaluation of HIV antigen and antibodies to p24 and gp41 in patients with hemophilia. Potential clinical importance.
    Allain JP; Laurian Y; Paul DA; Verroust F; Leuther M; Gazengel C; Senn D; Larrieu MJ; Bosser C
    N Engl J Med; 1987 Oct; 317(18):1114-21. PubMed ID: 3477695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
    Fahey JL; Taylor JM; Detels R; Hofmann B; Melmed R; Nishanian P; Giorgi JV
    N Engl J Med; 1990 Jan; 322(3):166-72. PubMed ID: 1967191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma viremia in human immunodeficiency virus infection.
    Coombs RW; Collier AC; Allain JP; Nikora B; Leuther M; Gjerset GF; Corey L
    N Engl J Med; 1989 Dec; 321(24):1626-31. PubMed ID: 2511447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blood antigens and specific anti-core and anti-envelope antibodies as markers of the course of HIV infection].
    Sorice F; Vullo V; Cirelli A; Catania S; Mastroianni CM; Contini C; Delia S
    Boll Ist Sieroter Milan; 1989; 68(2):115-21. PubMed ID: 2562362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progression to AIDS among HIV-seropositive hemophiliacs].
    Lorenzo JI; Molina R; Senent ML; Monzó E; Lerma MA; Dasí MA; Monteagudo E; Aznar JA
    Sangre (Barc); 1992 Jun; 37(3):169-74. PubMed ID: 1440093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with progression to AIDS and mortality in a cohort of HIV-infected patients with hemophilia followed up since seroconversion.
    Santagostino E; Gringeri A; Cultraro D; Tradati F; Siracusano L; Marinoni A; Mannucci PM
    Cell Mol Biol (Noisy-le-grand); 1995 May; 41(3):371-80. PubMed ID: 7580830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic marker paths for seroconversion: single determinations of immunoglobulin A and beta 2-microglobulin are not adequate to estimate time of HIV infection. Multicohort Analysis Project Workshop. Part II.
    AIDS; 1994 Jul; 8(7):923-33. PubMed ID: 7946101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study Group.
    McKinney RE; Maha MA; Connor EM; Feinberg J; Scott GB; Wulfsohn M; McIntosh K; Borkowsky W; Modlin JF; Weintrub P
    N Engl J Med; 1991 Apr; 324(15):1018-25. PubMed ID: 1672443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive markers for the acquired immunodeficiency syndrome (AIDS) in hemophiliacs: persistence of p24 antigen and low T4 cell count.
    Eyster ME; Ballard JO; Gail MH; Drummond JE; Goedert JJ
    Ann Intern Med; 1989 Jun; 110(12):963-9. PubMed ID: 2567142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum and immunological markers of progression to acquired immunodeficiency syndrome in hemophiliacs].
    Navarro MD; Flores JM; Wichmann I; Rey C; Velardo MA; Pineda JA; Leal M; Lissen E
    Med Clin (Barc); 1989 Mar; 92(11):405-8. PubMed ID: 2786123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Natural history of human immunodeficiency virus infection in a cohort of Chilean patients].
    Vial PA; Ferreccio C; Abarca K; Ortiz E; Noriega M; Pérez C; Labarca J; Torres M; Ferrés M; González C; Acuña G
    Rev Med Chil; 1996 May; 124(5):525-35. PubMed ID: 9035503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The prognostic markers of survival and progression in HIV-1 infection. A study of CD4+ lymphocytes, antigen p24 and viral load during 3 years in a cohort of 251 patients].
    Rubio Caballero M; Nogués Biau A; Falguera Sacrest M; Puig Ganau T; Lecha N; Rubio Rivas C
    An Med Interna; 2000 Oct; 17(10):533-7. PubMed ID: 11109648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-nef antibodies and other predictors of disease progression in HIV-1 seropositive injecting drug users.
    Rezza G; Titti F; Pezzotti P; Sernicola L; Lo Caputo S; Angarano G; Lazzarin A; Sinicco A; Rossi GB; Verani P
    J Biol Regul Homeost Agents; 1992; 6(1):15-20. PubMed ID: 1359736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virologic and immunologic characterization of symptomatic and asymptomatic primary HIV-1 infection.
    Henrard DR; Daar E; Farzadegan H; Clark SJ; Phillips J; Shaw GM; Busch MP
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):305-10. PubMed ID: 7788430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of HIV infection in the post-HAART era among a cohort of HIV+ Greek haemophilia patients.
    Katsarou O; Touloumi G; Antoniou A; Kouramba A; Hatzakis A; Karafoulidou A
    Haemophilia; 2005 Jul; 11(4):360-5. PubMed ID: 16011588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships among the detection of p24 antigen, human immunodeficiency virus (HIV) RNA level, CD4 cell count, and disease progression in HIV-infected individuals with hemophilia.
    Sabin CA; Lepri AC; Devereux H; Phillips AN; Loveday C; Lee CA
    J Infect Dis; 2001 Aug; 184(4):511-4. PubMed ID: 11471111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study.
    O'Brien TR; Blattner WA; Waters D; Eyster E; Hilgartner MW; Cohen AR; Luban N; Hatzakis A; Aledort LM; Rosenberg PS; Miley WJ; Kroner BL; Goedert JJ
    JAMA; 1996 Jul; 276(2):105-10. PubMed ID: 8656501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.